Net Loss Per Share - Narrative (Details) - Convertible Note and Warrant Purchase Agreement - Convertible Debt - $ / shares |
Mar. 31, 2026 |
Mar. 13, 2026 |
Aug. 01, 2025 |
|---|---|---|---|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Number of common stock called by warrants (in shares) | 550,000 | ||
| 2025 U.S. Bounti Warrant | |||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Number of common stock called by warrants (in shares) | 550,000 | 550,000 | |
| Warrant price (in dollars per share) | $ 0.125 | $ 0.125 | |
| 2026 U.S. Bounti Warrant | |||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Number of common stock called by warrants (in shares) | 5,500,000 | ||
| Warrant price (in dollars per share) | $ 0.125 | $ 0.125 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|